BioCryst Pharmaceuticals to merge with Idera Pharma; firm to be based in Pennsylvania
Durham-based BioCryst Pharmaceuticals has signed a definitive merger agreement with Idera Pharmaceuticals. Biocryst board chair Bob Ingram will lead the board of the merged firm.
Read More
